HCW Biologics (NASDAQ:HCWB) Downgraded by Wall Street Zen to “Sell”
Wall Street Zen cut shares of HCW Biologics (NASDAQ:HCWB – Free Report) from a hold rating to a sell rating in a report published on Saturday morning. Separately, Maxim Group reduced their price objective on shares of HCW Biologics from $120.00 to $35.00 and set a “buy” rating on the stock in a research note […]
Wall Street Zen cut shares of HCW Biologics (NASDAQ:HCWB – Free Report) from a hold rating to a sell rating in a report published on Saturday morning. Separately, Maxim Group reduced their price objective on shares of HCW Biologics from $120.00 to $35.00 and set a “buy” rating on the stock in a research note […]
